Key PointsIngrezza remains Neurocrine's biggest revenue driver, with sales growing 15%.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
Where Will Neurocrine Biosciences Be in 5 Years?
Key PointsIngrezza remains Neurocrine's biggest revenue driver, with sales growing 15%.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。